CD79A and amyotrophic lateral sclerosis: We estimated the proportions of anti-YghJ IgA that targeted glycosylated YghJ epitopes (GSP) in the 19 ALS and 10 saliva specimens that had been collected from the responders on Day 7 (for ALS) and Day 10 (for saliva).